NASDAQ •
Basic Materials •
Agricultural Inputs •
Quote as of 06/01/2026 16:00
Company Profile
IndustryAgricultural Inputs
SectorBasic Materials
ExchangeNASDAQ
Market Capitalization4.23 mln
Float0.43 mln
Piotroski F-Score
4
/ 9
Borderline
Relative Strength
88
/ 100
Strongly outperforming
Debt / Equity
0.04
Debt-free
Pre-Tax Margin
10,639%
Exceptional margin
ROE
-98.61
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Nexentis Technologies Inc. is an Israel-based company founded in 2009 that uses artificial intelligence and data tools to discover and develop small-molecule drug candidates, with a primary focus on hard-to-treat cancers and inflammatory metabolic diseases. Its core drug discovery work targets a specific family of mitochondrial proteins and is supported by early-stage research showing promising results in human-relevant models. The company also holds investments in solar energy projects across several European Union countries and offers treatment technologies that help reduce harmful pathogens in fresh produce. Formerly known as N2OFF Inc., Nexentis serves customers across the biotech, pharmaceutical, renewable energy, and agricultural industries.
